Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

DNA methylation at an enhancer of the three prime repair exonuclease 2 gene (TREX2) is linked to gene expression and survival in laryngeal cancer.

Weigel C, Chaisaingmongkol J, Assenov Y, Kuhmann C, Winkler V, Santi I, Bogatyrova O, Kaucher S, Bermejo JL, Leung SY, Chan TL, Lasitschka F, Bohrer MH, Marx A, Haußen RH, Herold-Mende C, Dyckhoff G, Boukamp P, Delank KW, Hörmann K, Lippert BM, Baier G, Dietz A, Oakes CC, Plass C, Becher H, Schmezer P, Ramroth H, Popanda O.

Clin Epigenetics. 2019 May 3;11(1):67. doi: 10.1186/s13148-019-0666-5.

2.

Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.

Uccelli L, Boschi A, Cittanti C, Martini P, Lodi L, Zappaterra E, Romani S, Zaccaria S, Cecconi D, Rambaldi I, Santi I, Panareo S, Giganti M, Bartolomei M.

Curr Radiopharm. 2018;11(2):130-137. doi: 10.2174/1874471011666180509101420.

PMID:
29745348
3.

Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.

Tamburini N, Maniscalco P, Mazzara S, Maietti E, Santini A, Calia N, Stefanelli A, Frassoldati A, Santi I, Rinaldi R, Nigim F, Righi R, Pedrazzi S, Cavallesco G.

Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1199-1204. doi: 10.1093/ejcts/ezx464.

PMID:
29293943
4.

Benthic pelagic coupling in a mesocosm experiment: Delayed sediment responses and regime shifts.

Dimitriou PD, Papageorgiou N, Geropoulos A, Kalogeropoulou V, Moraitis M, Santi I, Tsikopoulou I, Pitta P, Karakassis I.

Sci Total Environ. 2017 Dec 15;605-606:637-645. doi: 10.1016/j.scitotenv.2017.06.239. Epub 2017 Jul 1.

PMID:
28672252
5.

The impact of silver nanoparticles on marine plankton dynamics: Dependence on coating, size and concentration.

Tsiola A, Pitta P, Callol AJ, Kagiorgi M, Kalantzi I, Mylona K, Santi I, Toncelli C, Pergantis S, Tsapakis M.

Sci Total Environ. 2017 Dec 1;601-602:1838-1848. doi: 10.1016/j.scitotenv.2017.06.042. Epub 2017 Jun 14.

PMID:
28628993
6.

The studies of ParA and ParB dynamics reveal asymmetry of chromosome segregation in mycobacteria.

Ginda K, Santi I, Bousbaine D, Zakrzewska-Czerwińska J, Jakimowicz D, McKinney J.

Mol Microbiol. 2017 Aug;105(3):453-468. doi: 10.1111/mmi.13712. Epub 2017 Jun 22.

7.

Autologous bone graft in the treatment of post-traumatic bone defects: a systematic review and meta-analysis.

Azi ML, Aprato A, Santi I, Kfuri M Jr, Masse A, Joeris A.

BMC Musculoskelet Disord. 2016 Nov 9;17(1):465. Review.

8.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.

Singh V, Dhar N, Pató J, Kolly GS, Korduláková J, Forbak M, Evans JC, Székely R, Rybniker J, Palčeková Z, Zemanová J, Santi I, Signorino-Gelo F, Rodrigues L, Vocat A, Covarrubias AS, Rengifo MG, Johnsson K, Mowbray S, Buechler J, Delorme V, Brodin P, Knott GW, Aínsa JA, Warner DF, Kéri G, Mikušová K, McKinney JD, Cole ST, Mizrahi V, Hartkoorn RC.

Mol Microbiol. 2017 Jan;103(1):13-25. doi: 10.1111/mmi.13535. Epub 2016 Oct 29.

9.

A light-induced shortcut in the planktonic microbial loop.

Ptacnik R, Gomes A, Royer SJ, Berger SA, Calbet A, Nejstgaard JC, Gasol JM, Isari S, Moorthi SD, Ptacnikova R, Striebel M, Sazhin AF, Tsagaraki TM, Zervoudaki S, Altoja K, Dimitriou PD, Laas P, Gazihan A, Martínez RA, Schabhüttl S, Santi I, Sousoni D, Pitta P.

Sci Rep. 2016 Jul 11;6:29286. doi: 10.1038/srep29286.

10.

Lifestyle factors and risk of leukemia and non-Hodgkin's lymphoma: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Garrone E, Fontana V, Stagnaro E.

Cancer Causes Control. 2016 Mar;27(3):367-75. doi: 10.1007/s10552-016-0713-x. Epub 2016 Jan 13.

PMID:
26759332
11.

Chronic diseases, medical history and familial cancer, and risk of leukemia and non-Hodgkin's lymphoma in an adult population: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Sola S, Fontana V, Stagnaro E.

Cancer Causes Control. 2015 Jul;26(7):993-1002. doi: 10.1007/s10552-015-0592-6. Epub 2015 May 16.

PMID:
25982034
12.

Chromosome organization and replisome dynamics in Mycobacterium smegmatis.

Santi I, McKinney JD.

MBio. 2015 Feb 17;6(1):e01999-14. doi: 10.1128/mBio.01999-14.

13.

Risk of leukaemia and residential exposure to air pollution in an industrial area in Northern Italy: a case-control study.

Parodi S, Santi I, Casella C, Puppo A, Montanaro F, Fontana V, Pescetto M, Stagnaro E.

Int J Environ Health Res. 2015;25(4):393-404. doi: 10.1080/09603123.2014.958136. Epub 2014 Sep 23.

PMID:
25245102
14.

Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.

Herrmann K, Buck AK, Schuster T, Abbrederis K, Blümel C, Santi I, Rudelius M, Wester HJ, Peschel C, Schwaiger M, Dechow T, Keller U.

Oncotarget. 2014 Jun 30;5(12):4050-9.

15.

Risk of non-Hodgkin's lymphoma and residential exposure to air pollution in an industrial area in northern Italy: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Vercelli M, Stagnaro E.

Arch Environ Occup Health. 2014;69(3):139-47. doi: 10.1080/19338244.2013.763756.

PMID:
24325744
16.

To what degree is the association between educational inequality and laryngeal cancer explained by smoking, alcohol consumption, and occupational exposure?

Santi I, Kroll LE, Dietz A, Becher H, Ramroth H.

Scand J Work Environ Health. 2014 May 1;40(3):315-22. doi: 10.5271/sjweh.3403. Epub 2013 Nov 18.

17.

Occupation and educational inequalities in laryngeal cancer: the use of a job index.

Santi I, Kroll LE, Dietz A, Becher H, Ramroth H.

BMC Public Health. 2013 Nov 19;13:1080. doi: 10.1186/1471-2458-13-1080.

18.

Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria.

Santi I, Dhar N, Bousbaine D, Wakamoto Y, McKinney JD.

Nat Commun. 2013;4:2470. doi: 10.1038/ncomms3470. Erratum in: Nat Commun. 2013;4:3913.

PMID:
24036848
19.

Adaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation network.

Di Palo B, Rippa V, Santi I, Brettoni C, Muzzi A, Metruccio MM, Grifantini R, Telford JL, Paccani SR, Soriani M.

PLoS One. 2013 Apr 9;8(4):e61294. doi: 10.1371/journal.pone.0061294. Print 2013.

20.

Infectious diseases and risk of leukemia and non-Hodgkin's lymphoma: a case-control study.

Parodi S, Santi I, Marani E, Casella C, Puppo A, Sola S, Fontana V, Stagnaro E.

Leuk Res. 2012 Nov;36(11):1354-8. doi: 10.1016/j.leukres.2012.08.016. Epub 2012 Aug 31.

PMID:
22940258
21.

FDG PET/CT predictive role in follicular lymphoma.

Lopci E, Zanoni L, Chiti A, Fonti C, Santi I, Zinzani PL, Fanti S.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):864-71. doi: 10.1007/s00259-012-2079-y. Epub 2012 Feb 22.

PMID:
22354449
22.

Recognition of morphometric vertebral fractures by artificial neural networks: analysis from GISMO Lombardia Database.

Eller-Vainicher C, Chiodini I, Santi I, Massarotti M, Pietrogrande L, Cairoli E, Beck-Peccoz P, Longhi M, Galmarini V, Gandolini G, Bevilacqua M, Grossi E.

PLoS One. 2011;6(11):e27277. doi: 10.1371/journal.pone.0027277. Epub 2011 Nov 4.

23.

Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.

Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, Santi I, Rummeny EJ, Ziegler S, Schwaiger M, Nekolla SG, Beer AJ.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1691-701. doi: 10.1007/s00259-011-1842-9. Epub 2011 Jun 18.

PMID:
21688050
24.

Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes.

Hemminki K, Santi I, Weires M, Thomsen H, Sundquist J, Bermejo JL.

BMC Cancer. 2010 Dec 21;10:688. doi: 10.1186/1471-2407-10-688.

25.

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

Castellucci P, Fuccio C, Rubello D, Schiavina R, Santi I, Nanni C, Allegri V, Montini GC, Ambrosini V, Boschi S, Martorana G, Marzola MC, Fanti S.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63. doi: 10.1007/s00259-010-1604-0. Epub 2010 Sep 17.

PMID:
20848281
26.

FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.

Lopci E, Santi I, Tani M, Maffione AM, Montini G, Castellucci P, Stefoni V, Rubello D, Fonti C, Zinzani P, Fanti S.

Q J Nucl Med Mol Imaging. 2010 Aug;54(4):436-41. Epub 2010 May 27.

PMID:
20823812
27.

What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?

Santi I, Brandt A, Hemminki K.

Ann Surg Oncol. 2011 Jan;18(1):300-1. doi: 10.1245/s10434-010-1189-7. Epub 2010 Jun 30. No abstract available.

PMID:
20589435
28.

Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.

Fuccio C, Castellucci P, Schiavina R, Santi I, Allegri V, Pettinato V, Boschi S, Martorana G, Al-Nahhas A, Rubello D, Fanti S.

Ann Nucl Med. 2010 Jul;24(6):485-92. doi: 10.1007/s12149-010-0390-x. Epub 2010 Jun 11.

PMID:
20544323
29.

FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study.

Lopci E, Santi I, Derenzini E, Fonti C, Savelli G, Bertagna F, Bellò M, Botto B, Huglo D, Morschhauser F, Zinzani P, Fanti S.

Ann Oncol. 2010 Sep;21(9):1877-83. doi: 10.1093/annonc/mdq024. Epub 2010 Feb 10.

PMID:
20147744
30.

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.

Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, Franceschelli A, Martorana G, Manferrari F, Fanti S.

J Nucl Med. 2009 Sep;50(9):1394-400. doi: 10.2967/jnumed.108.061507. Epub 2009 Aug 18. Erratum in: J Nucl Med. 2009 Oct;50(10):1578.

31.

BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.

Santi I, Maione D, Galeotti CL, Grandi G, Telford JL, Soriani M.

J Infect Dis. 2009 Aug 15;200(4):564-70. doi: 10.1086/603540.

PMID:
19586417
32.

CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Santi I, Grifantini R, Jiang SM, Brettoni C, Grandi G, Wessels MR, Soriani M.

J Bacteriol. 2009 Sep;191(17):5387-97. doi: 10.1128/JB.00370-09. Epub 2009 Jun 19.

33.

Group B streptococcus pullulanase crystal structures in the context of a novel strategy for vaccine development.

Gourlay LJ, Santi I, Pezzicoli A, Grandi G, Soriani M, Bolognesi M.

J Bacteriol. 2009 Jun;191(11):3544-52. doi: 10.1128/JB.01755-08. Epub 2009 Mar 27.

34.

Functional characterization of a newly identified group B Streptococcus pullulanase eliciting antibodies able to prevent alpha-glucans degradation.

Santi I, Pezzicoli A, Bosello M, Berti F, Mariani M, Telford JL, Grandi G, Soriani M.

PLoS One. 2008;3(11):e3787. doi: 10.1371/journal.pone.0003787. Epub 2008 Nov 21.

35.

Pilus backbone contributes to group B Streptococcus paracellular translocation through epithelial cells.

Pezzicoli A, Santi I, Lauer P, Rosini R, Rinaudo D, Grandi G, Telford JL, Soriani M.

J Infect Dis. 2008 Sep 15;198(6):890-8. doi: 10.1086/591182.

PMID:
18694342
36.

BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.

Santi I, Scarselli M, Mariani M, Pezzicoli A, Masignani V, Taddei A, Grandi G, Telford JL, Soriani M.

Mol Microbiol. 2007 Feb;63(3):754-67. Epub 2007 Jan 8.

37.

Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.

Rosini R, Rinaudo CD, Soriani M, Lauer P, Mora M, Maione D, Taddei A, Santi I, Ghezzo C, Brettoni C, Buccato S, Margarit I, Grandi G, Telford JL.

Mol Microbiol. 2006 Jul;61(1):126-41.

38.

Group B Streptococcus crosses human epithelial cells by a paracellular route.

Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL.

J Infect Dis. 2006 Jan 15;193(2):241-50. Epub 2005 Dec 9.

PMID:
16362888
39.

Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.

Santi I, Monti M, Viganò A, D'Aprile E, Rampoldi E, Castellani L, Accinni R, Cunietti E.

Int J Biol Markers. 1995 Apr-Jun;10(2):107-12.

PMID:
7561234
40.

A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.

Ghigo E, Goffi S, Arvat E, Imperiale E, Boffano GM, Valetto MR, Mazza E, Santi I, Magliona A, Boghen MF, et al.

J Endocrinol Invest. 1992 Oct;15(9):665-70.

PMID:
1479149
41.

Plasma monomeric calcitonin as a marker of disease activity in multiple myeloma patients with osteolysis.

Monti M, Scazzoso A, Bevilacqua M, Santi I, D'Aprile E, Saligari A, Norbiato G, Cunietti E.

Int J Biol Markers. 1992 Apr-Jun;7(2):87-92.

PMID:
1634826
42.

Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.

Monti M, Scazzoso A, Calzaferri G, Santi I, D'Aprile E, Cunietti E.

Int J Biol Markers. 1990 Apr-Jun;5(2):61-4.

PMID:
2283478
43.

Serum type III procollagen propeptide levels in acromegalic patients.

Verde GG, Santi I, Chiodini P, Cozzi R, Dallabonzana D, Oppizzi G, Liuzzi A.

J Clin Endocrinol Metab. 1986 Dec;63(6):1406-10.

PMID:
2878008

Supplemental Content

Support Center